rL tw

u
if e e
S cie n c e N

Cambridge
HEALTHTECH
Institute

Your Cambridge
Life Science Network
HEALTHTECH
Institute

Cambridge
HEALTHTECH
Institute

Conference, Short Course, and

Training Seminar Catalog
March 2018 – August 2018

CHI is a division of
Cambridge Innovation Institute
RESEARCH • COLLABORATION • ADVANCEMENT
TABLE OF CONTENTS CONTACT US
CONFERENCE SERIES CUSTOMER SERVICE
Biological Therapeutic Products....................................................... 4 Pamela Gerardi
Director of Customer Service
Healthcare........................................................................................ 4 E: pgerardi@healthech.com | T: 781-972-5409
Biomarkers and Diagnostics............................................................ 5 Kris Waterman
Sr. Customer Service Representative
Bioprocess and Manufacturing........................................................ 5
E: kwaterman@healthtech.com | T: 781-972-5413
Clinical Trials & Translational Medicine............................................. 6 Rose LaRaia
Chemistry........................................................................................ 6 Customer Service Representative
E: rlaraia@healthtech.com | T: 781-972-5400
BioPharmaceutical Strategy............................................................. 7
Drug Discovery & Development...................................................... 7 MARKETING
Detection......................................................................................... 7 Jim MacNeil
Drug Targets..................................................................................... 8 Vice President of Marketing
E: jmacneil@healthtech.com | T: 781-972-5441
Genomics......................................................................................... 8 Rich Handy
Informatics and IT............................................................................ 8 Senior Director of Marketing
Therapeutic Indications.................................................................... 9 E: rhandy@healthtech.com | T: 781-972-5456

Technology and Tools for Life Sciences............................................ 9 SPONSOR & EXHIBIT SALES
CONFERENCES BY DATE WITH DETAIL.....................................11-12 Angela Parsons
Vice President of Business Development
E: aparsons@healthtech.com | T: 781-972-5467
SHORT COURSES AND TRAINING SEMINARS........................ 13-14
Joseph Vacca, M.S.,
Director, Business Development
E: jvacca@healthtech.com | T: 781-972-5431
About Cambridge Healthtech Institute GROUP SALES
For over 25 years, Cambridge Healthtech Institute has developed more than 800 David Cunningham
conferences, which have attracted over 60,000 attendees from around the world. Director, Inside Sales
CHI is the industry leader in offering quality programs that provide valuable new E: cunningham@healthtech.com | T: 781-972-5472
insights and competing points of view while offering balanced coverage of the latest
GRAPHICS
developments in the life science industry. Leading researchers and business experts
from top pharmaceutical, biotech, and academic organizations present their most Thomas Norton
current findings in a forum that features panel discussions and audience participation. Design Director
E: tnorton@healthtech.com | T: 781-972-5440
Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical
industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, PRODUCTION
Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, Edel O’ Regan, Ph.D.
and Business. Vice President of Production
E: eoregan@healthtech.com | T: 781-972-5423
For a comprehensive listing and detailed information about our products and services,
please visit: healthtech.com. Christina Lingham
Executive Director, Conferences and Fellow
E: clingham@healthtech.com | T: 781-972-5464
Mary Ann Brown
Follow us Executive Director of Conferences
E: mabrown@healthtech.com | T: 781-972-5497
Julia Boguslavsky
LinkedIn.com/company/Cambridge-Healthtech-Institute Executive Director of Conferences
E: juliab@healthtech.com | T: 760-732-3139
Micah Lieberman
Executive Director of Conferences
Facebook.com/HealthtechConferences E: mlieberman@healthtech.com | T: 541-482-4709
Marina Filshtinsky
Executive Director of Conferences
@CHI_Healthtech E: mfilshtinsky@healthtech.com | T: 781-97205496

Cambridge Healthtech Institute

YouTube.com/user/CambridgeHealthtech 250 First Avenue, Suite 300 | Needham, MA 02494
T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288
F: (781) 972-5425
2 | Cambridge Healthtech Institute
2018 KEY EVENTS
Drug Discovery
Chemistry
April 2-6, 2018 April 30 – May 4, 2018
Hilton San Diego Bayfront Seaport World Trade Center
San Diego, CA Boston, MA
DrugDiscoveryChemistry.com PEGSummit.com

May 15-17, 2018 June 11-13, 2018

Seaport World Trade Center The Westin Boston Waterfront
Boston, MA Boston, MA
Bio-ITWorldExpo.com BiomarkerWorldCongress.com

June 18-21, 2018 August 13-17, 2018

The Westin Copley Place Sheraton Boston
Boston, MA Boston, MA
WorldPreclinicalCongress.com BioprocessingSummit.com

Next Generation
SUMMIT
August 20-24, 2018
Grand Hyatt Washington
Washington, DC
NextDenerationDx.com

ONE STOP SHOP AFFILIATED REPORTS

COLLECTION

for Over 1,000 Life Science Reports Spanning over 50 Research Areas
An Essential Collection of Timely & Concise Reports Analyzing the
Technologies, Markets, and Strategic Issues Driving R&D Productivity.
Just some of the Reports Available Include:
Available through Insight Pharma Reports and our Network of Affiliated Reports.
• Alzheimer’s Disease • Data Mining
• Biomarkers & Diagnostics • Drug Discovery & Development
Insight Pharma Reports offers: • BioPharma Strategy • Health IT
• Biosimilars & Generic Markets • Infectious Disease
4 Market Data 4 Market Research • Cancer Research and Therapeutics • Medical Devices
4 Pipeline Data 4 Custom Reports • Chemistry • Multiple Sclerosis
• Clinical Trials & • Ocular
4 Clinical Trial Data 4 Bundled Report Packages Translational Medicine • Pain Management
• Pharmaceutical Marketing
• Sequencing
For more information, contact Daniel Miller at: • Vaccines
DMiller@InsightPharmaReports.com or call (781) 972-5492 ...and many others

InsightPharmaReports.com
March 2018 – August 2018 | 3
Conferences by Series
Biological Therapeutic
Products
Biotherapeutics Analytical Summit
Mar. 12-16 • Baltimore, MD
Method Development, Qualification &
Validation
Mar. 12-13 • Baltimore, MD
Characterizing Aggregates & Impurities
Mar. 12-13 • Baltimore, MD
Advances in Characterization Methods &
Approaches
Mar. 13-14 • Baltimore, MD
Comparability & Biosimilarity
Mar. 15-16 • Baltimore, MD
Immuno-Oncology Summit Europe
Mar. 19-23 • London, UK
Adoptive T-Cell Therapy
Mar. 19-20 • London, UK
Combination Immunotherapy
Mar. 20-21 • London, UK
Immunomodulatory Antibodies
Mar. 22-23 • London, UK
Oligonucleotide Discovery and Delivery
Mar. 26-28 • Cambridge, MA
Peptide Discovery and Delivery
Mar. 26-27 • Cambridge, MA
Display of Antibodies
Apr. 30 - May 1• Boston, MA
Difficult to Express Proteins
Apr. 30 - May 1• Boston, MA
Emerging Indications for Therapeutic
Antibodies
Apr. 30 - May 1• Boston, MA
Characterization of Biotherapeutics
Apr. 30 - May 1 • Boston, MA
Antibodies for Cancer Therapy
Apr. 30 - May 1 • Boston, MA
Improving Immunotherapy Efficacy and
Safety
Apr. 30 - May 1 • Boston, MA
Bridge to Pop Health East
May 14-15 • Boston, MA
Integrating Your Predictive Models into
Your Clinical Workflow
May 14-15 • Boston, MA
4 | Cambridge Healthtech Institute
Fusion Protein Therapeutics
Apr. 30 - May 1 • Boston, MA
Engineering Antibodies
May 2-3 • Boston, MA
Biophysical Analysis of Biotherapeutics
May 2-3 • Boston, MA
Immunogenicity Assessment and
Regulatory Approval of Biologics
May 2-3 • Boston, MA
Engineering Antibody-Drug Conjugates
May 2-3 • Boston, MA
Advancing Bispecific Antibodies and
Combination Therapy to the Clinic
May 2-3 • Boston, MA
CAR Ts, TCRs and TILs
May 2-3 • Boston, MA
CRISPR for Genome Engineering
May 2-3 • Boston, MA
Protein Aggregation and Stability in
Biopharmaceuticals
May 3-4 • Boston, MA
Engineering Bispecific Antibodies
May 3-4 • Boston, MA
Agonist Immunotherapy Targets
May 3-4 • Boston, MA
Clinical Progress of Antibody-Drug
Conjugates
May 3-4 • Boston, MA
Optimizing Bioassays for Biologics
May 3-4 • Boston, MA
Combination Immunotherapy
Jun. 11-12 • Boston, MA
Intrinsic and Acquired Resistance to
Immunotherapy
Jun. 12-13 • Boston, MA
Preclinical Strategies, Models & Tools in
Oncology
Jun. 19-20 • Boston, MA
Innovation in Clinical Care Delivery in a
Value-Based World
May 14-15 • Boston, MA
Data Visualization & Exploration Tools
May 15-17 • Boston, MA
Optimizing Drug Metabolism &
Pharmacokinetics
Jun. 19-20 • Boston, MA
Predicting Drug Toxicity
Jun. 20-21 • Boston, MA
Tumor Models for Cancer
Immunotherapy
Jun. 20-21 • Boston, MA
Translational Strategies in CNS
Jun. 20-21 • Boston, MA
Immuno-Oncology Targets
Jun. 20-21 • Boston, MA
Extracellular Vesicles
Jun. 20-21 • Boston, MA
Gene Therapy Bioproduction
Aug. 16-17 • Boston, MA
The Immuno-Oncology Summit
Aug. 27-31 • Boston, MA
Rational Combination Cancer
Immunotherapy
Aug. 27-28 • Boston, MA
Immunomodulatory Therapeutic
Antibodies for Cancer
Aug. 27-28 • Boston, MA
Oncolytic Virus Immunotherapy
Aug. 27-28 • Boston, MA
Adoptive T Cell Therapy 1: Discovery
Aug. 28-29 • Boston, MA
Preclinical and Translational Immuno-
Oncology
Aug. 28-29 • Boston, MA
Bispecific Antibodies for Cancer
Immunotherapy
Aug. 28-29 • Boston, MA
Emerging Immuno-Oncology Targets
Aug. 30-31 • Boston, MA
Neoantigen Targeted Therapies
Aug. 30-31 • Boston, MA
Adoptive T Cell Therapy 2: Development
Aug. 30-31 • Boston, MA
Mastering Medicinal Chemistry Part 1
Jun. 19-20 • Boston, MA
Mastering Medicinal Chemistry Part 2
Jun. 20-21 • Boston, MA

Bioinformatics
May 15-17 • Boston, MA
BIOSENSORS: Medical Sensors for
Integrated Healthcare Applications
May 16-17 • Boston, MA
Molecular Diagnostics Europe
May 22-24 • Lisbon, Portugal
Advances in Prenatal Molecular
Diagnostics
May 22-23 • Lisbon, Portugal
Clinical Application of Cell-Free DNA
May 22-23 • Lisbon, Portugal
Advanced Diagnostics for Infectious
Disease
May 22-23 • Lisbon, Portugal
Point-of-Care Diagnostics
May 23-24 • Lisbon, Portugal
Circulating Tumour Cells
May 23-24 • Lisbon, Portugal
Biomarkers & Immuno-Oncology World
Congress
Jun. 11-13 • Boston, MA
Clinical and Translational Biomarkers
Jun. 11-12 • Boston, MA
Immuno-Oncology Biomarkers 1:
Predictive Biomarkers and Companion
Diagnostics
Jun. 11-12 • Boston, MA
Digital Biomarkers: Biosensors,
Wearables, and mHealth
Jun. 11-12 • Boston, MA
Immuno-Oncology Biomarkers
2: Immune Profiling and Immune
Monitoring
Jun. 12-13 • Boston, MA
Bioprocessing Summit Europe
Mar. 20-22 • Lisbon, Portugal
Optimising Cell Culture Technology
Mar. 20-21 • Lisbon, Portugal
Continuous Processing for
Biopharmaceuticals
Mar. 20-21 • Lisbon, Portugal
Advances in Recovery and Purification
Mar. 21-22 • Lisbon, Portugal
Bioproduction: Scale, Bioreactors and
Disposables
Mar. 21-22 • Lisbon, Portugal
Targeting Complex Membrane Proteins
Apr. 4-5 • San Diego, CA
Biomarkers for Patient Selection
Jun. 12-13 • Boston, MA
Translational Strategies in CNS
Jun. 20-21 • Boston, MA
Extracellular Vesicles
Jun. 20-21 • Boston, MA
The Liquid Biopsy Summit
Jun. 20-22 • San Francisco, CA
Biodefense World Summit
Jun. 27-29 • Bethesda, MD
Biodetection Technologies: Biothreat and
Pathogen Detection
Jun. 26-27 • Bethesda, MD
Rapid Detection for Food Safety
Jun. 27-28 • Bethesda, MD
Biosurveilance Integration
Jun. 29 • Bethesda, MD
Biodetection Technologies: Point-of-Care
for Biodefense
Jun. 27-28 • Bethesda, MD
Next Generation Dx Summit
Aug. 20-24 • Washington, DC
Enabling Point-of-Care Diagnostics
Aug. 20-21 • Washington, DC
Companion Diagnostics: Strategy and
Partnership
Aug. 20-21 • Washington, DC
Clinical NGS Assays
Aug. 20-21 • Washington, DC
Biomarkers for Cancer Immunotherapy
and Combinations
Aug. 20-21 • Washington, DC
Sample Prep, Assay Development and
Validation
Aug. 22-23 • Washington, DC
Difficult to Express Proteins
Apr. 30 - May 1 • Boston, MA
Characterization of Biotherapeutics
Apr. 30 - May 1 • Boston, MA
Biophysical Analysis of Biotherapeutics
May 2-3 • Boston, MA
Optimizing Protein Expression
May 2-3 • Boston, MA
Immunogenicity Assessment and
Regulatory Approval of Biologics
May 2-3 • Boston, MA
Protein Aggregation and Stability in
Biopharmaceuticals
May 3-4 • Boston, MA
Conferences by Series
Molecular Diagnostics for Infectious
Disease
Aug. 22-23 • Washington, DC
Companion and Complementary
Diagnostics in Immuno-Oncology
Aug. 22-23 • Washington, DC
Commercializing Molecular Diagnostics
in Pharma, Healthcare and the Clinic
Aug. 22-23 • Washington, DC
Clinical Application of Cell-Free DNA
Aug. 22-23 • Washington, DC
Coverage and Reimbursement for
Advanced Diagnostics
Aug. 23-24 • Washington, DC
Single Cell Analysis
Aug. 23-24 • Washington, DC
Microfluidics and Lab-on-a-Chip Devices
for POCT
Aug. 23-24 • Washington, DC
The Immuno-Oncology Summit
Aug. 27-31 • Boston, MA
Oncolytic Virus Immunotherapy
Aug. 27-28 • Boston, MA
Immuno-Oncology Biomarkers 1:
Quantitative Immune Profiling and
Immune Monitoring
Aug. 27-28 • Boston, MA
Immuno-Oncology Biomarkers 2:
Predictive Biomarkers and Companion
Diagnostics
Aug. 28-29 • Boston, MA
Immuno-Oncology Investing and
Partnering Forum
Aug. 30 • Boston, MA
Optimizing Bioassays for Biologics
May 3-4 • Boston, MA
Protein Expression System Engineering
May 3-4 • Boston, MA
The Bioprocessing Summit
Aug. 13-17 • Boston, MA
Optimizing Cell Culture Technology
Aug. 13-14 • Boston, MA
Overcoming Formulation Challenges for
Biopharmaceuticals Development
Aug. 13-14 • Boston, MA
Rapid Methods to Assess Quality &
Stability of Biologics
Aug. 13-14 • Boston, MA
March 2018 – August 2018 | 5
Conferences by Series
Continuous Processing in Biopharm Bioproduction: Scale, Bioreactors &
Manufacturing Disposables
Aug. 13-14 • Boston, MA Aug. 15-16 • Boston, MA
Cell Therapy CMC and Analytics Accelerating Analytical Development
Aug. 13-14 • Boston, MA Aug. 15-16 • Boston, MA
Host Cell Proteins Advances in Purification & Recovery
Aug. 13-14 • Boston, MA Aug. 15-16 • Boston, MA
High-Concentration Protein Formulations Cell Therapy Manufacturing
Aug. 15-16 • Boston, MA Aug. 15-16 • Boston, MA
Gene Therapy CMC and Analytics
Aug. 15-16 • Boston, MA
Manufacturing 4.0
Aug. 15-16 • Boston, MA
Detection, Characterization and Control
of Impurities in Biologics
Aug. 16-17 • Boston, MA
Optimizing Cell Line Development
Aug. 16-17 • Boston, MA
Process Characterization and Control
Aug. 16-17 • Boston, MA
Gene Therapy Bioproduction
Aug. 16-17 • Boston, MA 


Immuno-Oncology Summit Europe Outsourcing for Clinical Trials Intrinsic and Acquired Resistance to
Mar. 19-23 • London, UK May 8-9 • Boston, MA Immunotherapy
Drug Discovery for Rare Diseases Data & Tech Driven Clinical Trials Jun. 12-13 • Boston, MA
Mar. 28 • Cambridge, MA May 8-9 • Boston, MA Precision Medicine
Immunogenicity Case Studies and Clinical Research & Translational Aug. 23-24 • Washington, DC
Clinical Management Informatics Biomarkers for Patient Selection
Apr. 30 - May 1 • Boston, MA May 15-17 • Boston, MA Jun. 12-13 • Boston, MA
Clinical Progress of Antibody-Drug Clinical Genomics Immuno-Oncology Biomarkers 2:
Conjugates May 15-17 • Boston, MA Predictive Biomarkers and Companion
May 3-4 • Boston, MA Cancer Informatics Diagnostics
Clinical Trial Innovation Summit May 15-17 • Boston, MA Aug. 28-29 • Boston, MA
May 7-9 • Boston, MA Biomarkers & Immuno-Oncology World Preclinical and Translational Immuno-
Mastering Risk-Based Monitoring: Congress Oncology
Ensuring Quality in Clinical Trials Jun. 11-13 • Boston, MA Aug. 28-29 • Boston, MA
May 7-8 • Boston, MA Clinical and Translational Biomarkers Personalized Cancer Vaccines
Patient Recruitment & Site Selection Jun. 11-12 • Boston, MA Aug. 30-31 • Boston, MA
May 7-8 • Boston, MA Digital Biomarkers: Biosensors, Immuno-Oncology Investing and
Big Data Analytics, Machine Learning, Wearables, and mHealth Partnering Forum
and Artificial Intelligence for Clinical Trials Jun. 11-12 • Boston, MA Aug. 30 • Boston, MA
May 7-8 • Boston, MA
Mastering Risk-Based Monitoring:
Effective Monitoring & Implementation
May 8-9 • Boston, MA

Oligonucleotide and Peptide Therapeutics Macrocyclics & Constrained Peptides Phenotypic Screening and Chemical
Boston Apr. 4-5 • San Diego, CA Biology
Mar. 26-28 • Cambridge, MA Small Molecules for Cancer Jun. 19-20 • Boston, MA
Drug Discovery Chemistry Immunotherapy Mastering Medicinal Chemistry - Part 1
Apr. 2-6 • San Diego, CA Apr. 4-5 • San Diego, CA Jun. 19-20 • Boston, MA
Fragment-Based Drug Discovery PEGS: The Essential Protein Engineering Mastering Medicinal Chemistry - Part 2
Apr. 3-4 • San Diego, CA Summit Jun. 20-21 • Boston, MA
Kinase Inhibitor Chemistry Apr. 30 - May 4 • Boston, MA
Apr. 3-4 • San Diego, CA

6 | Cambridge Healthtech Institute


Method Development, Qualification &
Validation
Mar. 12-13 • Baltimore, MD
Characterizing Aggregates & Impurities
Mar. 12-13 • Baltimore, MD
Advances in Characterization Methods &
Approaches
Mar. 13-14 • Baltimore, MD
Oligonucleotide and Peptide Therapeutics
Mar. 26-28 • Cambridge, MA
Oligonucleotide Discovery and Delivery
Mar. 26-28 • Cambridge, MA
Peptide Discovery and Delivery
Mar. 26-27 • Cambridge, MA
Drug Discovery for Rare Diseases
Mar. 28 • Cambridge, MA
Drug Discovery Chemistry
Apr. 2-6 • San Diego, CA
Small Molecules for Cancer
Immunotherapy
Apr. 4-5 • San Diego, CA
Lead Optimization for Drug Metabolism
and Safety
Apr. 6 • San Diego, CA
PEGS: The Essential Protein Engineering
Summit
Apr. 30 - May 4 • Boston, MA
Improving Immunotherapy Efficacy and
Safety
Apr. 30 - May 1 • Boston, MA
Fusion Protein Therapeutics
Apr. 30 - May 1 • Boston, MA
Engineering Antibodies
May 2-3 • Boston, MA
Nanotechnology in Medicine
May 3-4 • Boston, MA
Enabling Point-of-Care Diagnostics
Aug. 20-21 • Washington, DC
Companion Diagnostics: Strategy and
Partnership
Aug. 20-21 • Washington, DC
Circulating Tumor Cells
Aug. 20-21 • Washington, DC
Comparability & Biosimilarity
Mar. 15-16 • Baltimore, MD
Peptide Discovery and Delivery
Mar. 26-27 • Cambridge, MA
Immunogenicity Case Studies and
Clinical Management
Apr. 30 - May 1 • Boston, MA
Strategic Alliance Management Congress
May 7-9 • Philadelphia, PA
CRISPR for Genome Engineering
May 2-3 • Boston, MA
Nanotechnology in Medicine
May 3-4 • Boston, MA
Pharmaceutical R&D Informatics
May 15-17 • Boston, MA
Machine Learning
May 15-17 • Boston, MA
Biomarkers & Immuno-Oncology World
Congress
Jun. 11-13 • Boston, MA
Combination Immunotherapy
Jun. 11-12 • Boston, MA
World Preclinical Congress
Jun. 18-21 • Boston, MA
CNS Disease Models
Jun. 19-20 • Boston, MA
Optimizing Drug Metabolism &
Pharmacokinetics
Jun. 19-20 • Boston, MA
iPS Cells for Disease Modeling and Drug
Discovery
June 19-20 • Boston, MA
Blood-Brain Barrier
Jun. 19-20 • Boston, MA
Biomarkers for Cancer Immunotherapy
and Combinations
Aug. 20-21 • Washington, DC
Sample Prep, Assay Development and
Validation
Aug. 22-23 • Washington, DC
Companion and Complementary
Diagnostics in Immuno-Oncology
Aug. 22-23 • Washington, DC
Commercializing Molecular Diagnostics
Aug. 22-23 • Washington, DC
Clinical Application of Cell-Free DNA
Aug. 22-23 • Washington, DC
Conferences by Series
Patient Recruitment & Site Selection
May 7-8 • Boston, MA
Outsourcing for Clinical Trials
May 8-9 • Boston, MA
Pharmaceutical R&D Informatics
May 15-17 • Boston, MA
Precision Medicine
Aug. 23-24 • Washington, DC
NanoDrugs: Design and Delivery
Jun. 19-20 • Boston, MA
Tumoroids for Oncology Research
Jun. 19-20 • Boston, MA
3D Cellular Models
Jun. 20-21 • Boston, MA
Predicting Drug Toxicity
Jun. 20-21 • Boston, MA
High-Content Analysis
Jun. 20-21 • Boston, MA
Next-Gen Genomics: Leveraging CRISPR
& Single-Cells
Jun. 20-21 • Boston, MA
Overcoming Formulation Challenges for
Biopharmaceuticals Development
Aug. 13-14 • Boston, MA
Rational Combination Cancer
Immunotherapy
August 27-28 • Boston, MA
Adoptive T Cell Therapy 1: Discovery
Aug. 28-29 • Boston, MA
Personalized Cancer Vaccines
Aug. 30-31 • Boston, MA
Immuno-Oncology Investing and
Partnering Forum
Aug. 30 • Boston, MA
Coverage and Reimbursement for
Advanced Diagnostics
Aug. 23-24 • Washington, DC
Microfluidics and Lab-on-a-Chip Devices
for POCT
Aug. 23-24 • Washington, DC
March 2018 – August 2018 | 7
Conferences by Series
Drug Targets
SERIES
Oligonucleotide and Peptide Therapeutics PEGS: The Essential Protein Engineering 3D Cellular Models
Boston Summit Jun. 20-21 • Boston, MA
Mar. 26-28 • Cambridge, MA Apr. 30 - May 4 • Boston, MA High-Content Analysis
Drug Discovery Chemistry Phenotypic Screening and Chemical Jun. 20-21 • Boston, MA
Apr. 2-6 • San Diego, CA Biology Translational Strategies in CNS
Kinase Inhibitor Chemistry Jun. 19-20 • Boston, MA Jun. 20-21 • Boston, MA
Apr. 3-4 • San Diego, CA NanoDrugs: Design and Delivery Bispecific Antibodies for Cancer
Protein-Protein Interactions Jun. 19-20 • Boston, MA Immunotherapy
Apr. 3-4 • San Diego, CA Tumoroids for Oncology Research Aug. 28-29 • Boston, MA
GPCR-Targeted Drug Design Jun. 19-20 • Boston, MA Emerging Immuno-Oncology Targets
Apr. 3-4 • San Diego, CA Aug. 30-31 • Boston, MA

Next-Gen Sequencing Informatics
May 15-17 • Lisbon, Portugal
Clinical Application of Cell-Free DNA
May 22-23 • Lisbon, Portugal
Biomarkers & Immuno-Oncology World
Congress
Jun. 11-13 • Boston, MA
Immuno-Oncology Biomarkers 2: Immune
Profiling and Immune Monitoring
Jun. 12-13 • Boston, MA
Next-Gen Genomics: Leveraging CRISPR
& Single-Cells
Jun. 20-21 • Boston, MA
Circulating Tumor Cells
Aug. 20-21 • Washington, DC
Clinical NGS Assays: Interpretation and
Clinical Utility
Aug. 20-21 • Washington, DC
Commercializing Molecular Diagnostics
in Pharma, Healthcare and the Clinic
Aug. 22-23 • Washington, DC
Single Cell Analysis
Aug. 23-24 • Washington, DC
Clinical Application of Cell-Free DNA
Aug. 22-23 • Washington, DC
Immuno-Oncology Biomarkers 1:
Quantitative Immune Profiling and
Immune Monitoring
Aug. 27-28 • Boston, MA
Neoantigen Targeted Therapies
Aug. 30-31 • Boston, MA

Clinical Trial Innovation Summit Bio-IT World Cancer Informatics

May 7-9 • Boston, MA May 15-17 • Boston, MA May 15-17 • Boston, MA
Big Data Analytics, Machine Learning, Data & Storage Management Data Security
and Artificial Intelligence for Clinical Trials May 15-17 • Boston, MA May 15-17 • Boston, MA
May 7-8 • Boston, MA Software Applications & Services Machine Learning
Mastering Risk-Based Monitoring: May 15-17 • Boston, MA May 15-17 • Boston, MA
Effective Monitoring & Implementation Data Computing Data Transfer
May 8-9 • Boston, MA May 15-17 • Boston, MA May 15-17 • Boston, MA
Data & Tech Driven Clinical Trials Cloud Computing Disease Surveillance & Modeling
May 8-9 • Boston, MA May 15-17 • Boston, MA May 15-17 • Boston, MA
Bridge to Pop Health East Bioinformatics Manufacturing 4.0
May 14-15 • Boston, MA May 15-17 • Boston, MA Aug. 15-16 • San Francisco, CA
Integrating Your Predictive Models into Next-Gen Sequencing Informatics
Your Clinical Workflow May 15-17 • Boston, MA
May 14-15 • Boston, MA
Clinical Genomics
Innovation in Clinical Care Delivery in a May 15-17 • Boston, MA
Value-Based World
May 14-15 • Boston, MA FAIR Data for Genomic Applications
May 15-17 • Boston, MA

8 | Cambridge Healthtech Institute


SERIES
Adoptive T-Cell Therapy
Mar. 19-20 • London, United Kingdom
Combination Immunotherapy
Mar. 20-21 • London, United Kingdom
Immunomodulatory Antibodies
Mar. 22-23 • London, United Kingdom
Inflammation and Autoimmune Inhibitors
Apr. 3-4 • San Diego, CA
Blood-Brain Penetrant Inhibitors
Apr. 6 • San Diego, CA
Emerging Indications for Therapeutic
Antibodies
Apr. 30 - May 1 • Boston, MA
Antibodies for Cancer Therapy
Apr. 30 - May 1 • Boston, MA
Engineering Antibody-Drug Conjugates
May 2-3 • Boston, MA
Advancing Bispecific Antibodies and
Combination Therapy to the Clinic
May 2-3 • Boston, MA
CAR Ts, TCRs and TILs
May 2-3 • Boston, MA
Agonist Immunotherapy Targets
May 3-4 • Boston, MA
Biotherapeutics Analytical Summit
Mar. 12-16 • Baltimore, MD
Comparability & Biosimilarity
Mar. 15-16 • Baltimore, MD
Oligonucleotide Discovery and Delivery
Mar. 26-28 • Cambridge, MA
Peptide Discovery and Delivery
Mar. 26-27 • Cambridge, MA
Targeting Complex Membrane Proteins
Apr. 4-5 • San Diego, CA
Ubiquitin Proteasome System Inhibitors
Apr. 4-5 • San Diego, CA
Biophysical Approaches for Drug
Discovery
Apr. 6 • San Diego, CA
Display of Antibodies
Apr. 30 - May 1 • Boston, MA
Optimizing Protein Expression
May 2-3 • Boston, MA
Protein Expression System Engineering
May 3-4 • Boston, MA
Immuno-Oncology Biomarkers 1:
Predictive Biomarkers and Companion
Diagnostics
Jun. 11-12 • Boston, MA
Preclinical Strategies, Models & Tools in
Oncology
Jun. 19-20 • Boston, MA
CNS Disease Models
Jun. 19-20 • Boston, MA
iPS Cells for Disease Modeling and Drug
Discovery
Jun. 19-20 • Boston, MA
Blood-Brain Barrier
Jun. 19-20 • Boston, MA
Tumor Models for Cancer Immunotherapy
Jun. 20-21 • Boston, MA
Immuno-Oncology Targets
Jun. 20-21 • Boston, MA
The Liquid Biopsy Summit
Jun. 20-22 • San Francisco, CA
Rapid Methods to Assess Quality &
Stability of Biologics
Aug. 13-14 • Boston, MA
Cell Therapy CMC and Analytics
Aug. 13-14 • Boston, MA
Bio-IT World
May 15-17 • Boston, MA
Data & Storage Management
May 15-17 • Boston, MA
Software Applications & Services
May 15-17 • Boston, MA
Data Computing
May 15-17 • Boston, MA
Cloud Computing
May 15-17 • Boston, MA
Clinical Research & Translational
Informatics
May 15-17 • Boston, MA
Data Visualization & Exploration Tools
May 15-17 • Boston, MA
FAIR Data for Genomic Applications
May 15-17 • Boston, MA
Cancer Informatics
May 15-17 • Boston, MA
Data Security
May 15-17 • Boston, MA
Conferences by Series
The Bioprocessing Summit
Aug. 13-17 • Boston, MA
Cell Therapy Manufacturing
Aug. 15-16 • Boston, MA
Detection, Characterization and Control
of Impurities in Biologics
Aug. 16-17 • Boston, MA
Process Characterization and Control
Aug. 16-17 • Boston, MA
Circulating Tumor Cells
Aug. 20-21 • Washington, DC
Biomarkers for Cancer Immunotherapy
and Combinations
Aug. 20-21 • Washington, DC
Immunomodulatory Therapeutic
Antibodies for Cancer
Aug. 27-28 • Boston, MA
Bispecific Antibodies for Cancer
Immunotherapy
Aug. 28-29 • Boston, MA
Adoptive T Cell Therapy 2: Development
Aug. 30-31 • Boston, MA
Data Transfer
May 15-17 • Boston, MA
Disease Surveillance & Modeling
May 15-17 • Boston, MA
Clinical Application of Circulating Cell-
Free DNA
May 22-23 • Lisbon, Portugal
Circulating Tumour Cells
May 23-24 • Lisbon, Portugal
Enabling Technologies for Cell-Free DNA
May 23-24 • Lisbon, Portugal
World Preclinical Congress
Jun. 18-21 • Boston, MA
Extracellular Vesicles
June 20-21 • Boston, MA
Biodefense World Summit
Jun. 27-29 • Bethesda, MD
Continuous Processing in Biopharm
Manufacturing
Aug. 13-14, 2018 • Boston, MA
Advances in Purification & Recovery
Aug. 15-16 • Boston, MA
March 2018 – August 2018 | 9
Conferences by Date with Detail
Biotherapeutics Analytical Summit
March 12-16, 2018 • Baltimore, MD
The Biotherapeutics Analytical Summit, with its hallmark brand of
topics on Method Development, Qualification & Validation, Advances
in Characterization Methods & Approaches and Comparability
& Biosimilarity, and its signature mix of regulators, industry and
academia speakers, has come to be known as THE Analytical
Summit where attendees can hear and learn about real-life case
studies, innovative concepts and practical approaches that can help
scientists advance their molecules from discovery to development
and commercialization. New this year is a dedicated conference
on “Characterizing Aggregates & Impurities.” Previously a part of
the Advances in Characterization Methods conference, we are
responding to your request to dedicate more time and focus on this
challenging and dynamic topic.
BiotherapeuticsAnalyticalSummit.com
Immuno-Oncology Summit Europe
March 19-23, 2018 • London, United Kingdom
Cambridge Healthtech Institute’s Third Annual Immuno-Oncology
Summit Europe returns to the heart of London’s Canary Wharf
for a full week of cutting-edge science and discussion. Through
three back-to-back conference tracks, delegates will hear from the
research teams at the forefront of the rapidly developing field of
cancer biotherapeutics. Cambridge Healthtech Institute brings you
the highest standard of scientific content and collaboration with
more than 130 conferences across the globe, including the industry
leading PepTalk, PEGS Protein & Antibody Engineering Summits and
Immuno-Oncology Summits held each year in North America, Europe
and Asia. We look forward to seeing you at what promises to be
another successful knowledge-sharing event.
Immuno-OncologyEurope.com
Bioprocessing Summit Europe
March 20-22, 2018 • Lisbon, Portugal
Bioprocessing Summit Europe brings together leading bioprocessing
scientists to share day-to-day challenges and practical solutions for
today’s bioprocessing needs. Created by the producers of PEGS,
PepTalk and The Bioprocessing Summit Boston, this four-conference,
scientifically driven event presents detailed case studies, technology
updates, and best practice in cell culture, scale-up, recovery,
purification, continuous manufacturing, process intensification, and
bioproduction. Along with the impressive array of conferences, the
Summit also features Short Courses, interactive Breakout Sessions
and a lively Exhibit Hall to provide in-depth coverage of critical
bioprocess topics.
BioprocessingEurope.com
10 | Cambridge Healthtech Institute
Oligonucleotide and Peptide
Therapeutics
March 26-28, 2018 • Cambridge, MA
It has been estimated that only a fraction of known disease targets
have been successfully met with therapeutic options. As our
understanding of disease biology continues to outpace our ability
to develop therapeutic agents, there is an urgent need to find new
ways to unlock a greater portion of this “undruggable” target space.
Oligonucleotide and peptide therapeutics have emerged as critical
development platforms to meet this challenge, poised to produce
highly specific, diverse and safe therapies while addressing a much
wider range of targets than traditional small molecules or biologics.
CHI’s Third Annual Oligonucleotide & Peptide Therapeutics (OPT)
Boston will once again convene leading developers and technology
providers to discuss advances in next-generation oligonucleotide
and peptide therapies. This three-day event includes two main
conferences covering topics within discovery, delivery, and early
clinical studies, as well as a symposium focused on utilizing
oligonucleotides and peptides to address rare diseases.
OPTCongress.com
Drug Discovery Chemistry
April 2-6, 2018 • San Diego, CA
Cambridge Healthtech Institute’s 13th Annual Drug Discovery
Chemistry is a dynamic conference for medicinal chemists working
in pharma and biotech. Focused on discovery and optimization
challenges of small molecule drug candidates, this event provides
many exciting opportunities for scientists to create a unique program
to hear presentations most suited to one’s personal interests by
going back and forth among concurrent meeting tracks. New for 2018
is expanded coverage of Small Molecules for Cancer Immunotherapy,
plus new coverage of Ubiquitin Proteasome System Inhibitors,
Targeting Complex Membrane Proteins, as well as Lead Optimization
for Drug Safety.
DrugDiscoveryChemistry.com
PEGS: The Essential Protein &
Antibody Engineering Summit
April 30, 2018 - May 4, 2018 • Boston, MA
PEGS: The Essential Protein Engineering Summit is one of the
industry’s most preeminent events that inspires accelerated
biotherapeutic protein drug development. This weeklong event
attracts over 2,300 international participants, and features nearly
400 presentations by world renowned leaders from pharma,
academia, and government showcasing case studies, cutting edge
data, insight and perspective. Conference programs include a broad
spectrum of topics including protein and antibody engineering, cancer
immunotherapy, oncology, and emerging therapeutics.
PEGSummit.com

Neurotech Investing & Partnering
Conference
May 1-2, 2018 • Boston, MA
Now in its 13th year, the Neurotech Investing & Partnering
Conference is the premier business and investment conference for
commercial neuroscience including pharmaceuticals, medical devices,
diagnostics and neurosoftware. The conference features keynotes,
investor panels, cutting edge company presentations, and panel
discussions on a comprehensive selection of neurotech topics. Our
goal is to provide a highly-interactive environment where cutting edge
technologies, devices, drugs and therapies inspire new collaborations
and secure financing to navigate the development path and ultimately
reach patients. The Neurotech Investing and Partnering Conference is
a global forum where investors, executives, entrepreneurs, scientists
and others involved in the development of new treatments and
diagnostics for the brain and nervous system come together to shape
the future of their organization and the industry. This market-defining
conference features keynotes on the state of the neurotech industry,
cutting edge company presentations, leading translational research
projects and panel discussions on a comprehensive selection of
neurotech topics.
NeurotechPartnering.com
Strategic Alliance Management
Congress
May 7-9, 2018 • Boston, MA
The approval of new therapies increasingly relies on an ecosystem
of strategic partnerships during various stages of the development
pipeline. Successfully managing these partnerships has become a
critical component to the underlying success of each partner and
the biopharma industry. As the quantity and complexity of deals
increase, alliance teams have rapidly evolved, developing innovative
strategies, systematic approaches and best practices to maximize
value, and to leverage strategic partnerships above and beyond
the deal. Cambridge Healthtech Institute’s 15th Annual Strategic
Alliance Management Congress, May 7-9, brings together senior
alliance management, business development, technology transfer
and licensing professionals, to network, share experiences, discuss
case studies, and to share the components that cultivate successful
partnerships. Delegates will gain strategic insights, proven tools,
methods, and perspectives from a variety of leaders advancing the art
of alliance management.
Healthtech.com/AMS
Clinical Trial Innovation Summit
May 7-9, 2018 • Boston, MA
Cambridge Healthtech Institute’s Clinical Trial Innovation Summit
brings together 250 leaders from across pharma, biotech and
academia for the perfect blend of high quality presentations and
intimate networking. Through case studies, interactive discussions
and an active exhibit hall, the summit delivers the real-world
experiences and best practices needed to optimize clinical trial
oversight. Presentations span across the most complex areas of
trial management, including patient recruitment, site selection,
data integration, existing data sources, mobile technologies, project
management, outsourcing, vendor management, budgeting and
contracting, quality (QbD) in trial conduct and risk-based monitoring.
ClinicalTrialSummit.com
Conferences by Date with Detail
Bridge to Pop Health East
May 14-15, 2018 • Boston, MA
Formerly known as Medical Informatics World, Cambridge
Healthtech Institute’s Sixth Annual Bridge to Pop Health Conference
in Boston brings together thought leaders from the provider,
payer, healthcare finance, analyst and technology communities for
insightful discussions on maximizing clinical quality. The two-day
executive conference will cover operational performance in risk-
based contracts, integrating your predictive models into your clinical
workflow, innovation in clinical care delivery in a value-based world,
and implementing a population health management strategy in the
transitional space between fee-for-service and value-based care. We
look forward to seeing you at what promises to be a productive step
forward for our industry.
BridgeToPopHealth.com/East
Bio-IT World
May 15-17, 2018 • Boston, MA
There’s been dramatic progress in life science technologies over the
years, yet the fundamental goal of the Bio-IT community remains
the same — to make the most of data and computing to advance
medicine. Since 2002, Bio-IT World has played an integral role in
this, bringing together clever, innovative people from all areas of life
sciences for expert commentary and industry insight. Our 2017 event
brought together more than 3,400 attendees from 35 countries to
make connections and forge collaborations across the life sciences.
Next year promises to be even better. With 16 tracks, 14 pre-
conference workshops, and three industry awards, the 2018 Bio-IT
World Conference & Expo will offer more opportunities to build the
relationships that drive the Bio-IT industry forward.
Bio-ITWorldExpo.com
Biosensors
May 16-17, 2018 • Boston, MA
Emerging technological innovations enabled by next-generation
sensors will define the landscape for the future commercialization of
life changing medical devices. The exponential growth of the global
sensors market and the demand for next-generation integrated
systems is expected to reach $18 billion by 2018. Low cost materials
and advances in nano and micro fabrication techniques within the
manufacturing process have led to significant increases in the
commercialization of sensors for healthcare applications. Cambridge
Healthtech Institute’s Biosensors conference, which will take place at
the Aloft Boston Seaport Hotel, will examine the latest advancements
in research and integration and will provide attendees with state-of-
the-art sensors development for medical applications.
MedicalBiosensors.com
Molecular Diagnostics Europe
May 22-24, 2018 • Lisbon, Portugal
Cambridge Healthtech Institute’s Sixth International Molecular
Diagnostics Europe event will return to Lisbon on 22-24 May
2018. This meeting provides a nexus for diagnostic developers in
academia and industry as well as end-users in the pharmaceutical
and healthcare sector to gain a comprehensive picture of molecular
diagnostics in prenatal, oncology, infectious disease, point-of-care,
liquid biopsy, and immunotherapy. This exciting area has attracted
attendance of over 400 delegates to learn what novel technologies,
platforms and applications are emerging that will impact future
healthcare delivery and pharmaceutical research. Join us next spring
at this expanding event at the epicenter of diagnostics.
MolecularDxEurope.com
March 2018 – August 2018 | 11
Conferences by Date with Detail
Biomarkers & Immuno-Oncology World
Congress
June 11-13, 2018 • Boston, MA
Cambridge Healthtech Institute’s Fourteenth Annual Biomarkers and
Immuno-Oncology World Congress, now in Boston, is our longest-
running event dedicated to all areas of biomarker research and
development spanning the pharmaceutical and diagnostic pipelines.
With the promising developments in immuno-oncology over the
past years, much of the biomarker R&D has shifted to discovery and
development of predictive biomarkers for immunotherapy patient
stratification, using biomarkers to choose rational combination
immunotherapy, and applying immune profiling to predict and
monitor response to immunotherapy. The Immuno-Oncology
Biomarkers stream will address predictive biomarkers and companion
diagnostics, as well as immune profiling and immune monitoring.
The Immunotherapy stream will address the two biggest challenges
in pharmaceutical IO programs: designing rational combination
immunotherapies and strategies to address intrinsic and acquired
resistance. Finally, a new track on Digital Biomarkers will cover the
clinical utility of biosensors, wearables and mobile health, and their
emerging applications in drug development.
BiomarkerWorldCongress.com
World Preclinical Congress
June 18 - 21 • Boston, MA
The 17th Annual World Preclinical Congress focuses on the latest
trends and technologies impacting drug discovery and translational
research. The Congress offers a unique opportunity for chemists,
biologists, pharmacologists, cancer researchers, neuroscience
scientists, toxicologists, bioengineers, screening experts and
translational scientists in industry and academia as well as technology
providers to come together and exchange expertise and opinions.
World Preclinical Congress is a key networking event yielding new
partnerships that accelerate preclinical research and translation across
all therapeutic areas.
WorldPreclinicalCongress.com
The Liquid Biopsy Summit
June 20-22, 2018 • San Francisco, CA
Participants from around the world convene at The Liquid Biopsy
Summit to share case studies, breakthroughs and solutions
that support and enhance their research, and discuss process
and technology refinements that are impacting the future of
precision medicine.
LiquidBiopsySummit.com
Biodefense World Summit
June 26-29, 2018 • Bethesda, MD
Cambridge Healthtech Institute’s Fourth Annual Biodefense World
Summit brings together leaders from government, academia, and
industry for compelling discussions and comprehensive coverage
on pathogen detection, point-of-care, biosurveillance, sample prep
technologies, and bio recovery. Across three days of programming,
attendees can expect exceptional networking opportunities in the
exhibit hall, engaging panel discussions, and shared case studies with
members of the biodefense community from technology providers to
policy makers. The 2017 summit saw more than 250 participants with
35% of attendees titled as scientist/technologist, 30% as executive/
director, and 11% as professor.
BiodefenseWorldSummit.com
12 | Cambridge Healthtech Institute
The Bioprocessing Summit
August 13-17, 2018 • Boston, MA
The Bioprocessing Summit convenes more than 1,000 international
bioprocess professionals to share practical solutions for today’s
bioprocess challenges. The event has grown to include 17 distinct
conferences with weeklong programming on upstream and
downstream processing, analytical development and quality,
formulation and stability, cell and gene therapy production, and
manufacturing. Along with the impressive array of conferences,
the Summit also includes short courses and training seminars that
provide in-depth coverage of critical bioprocess topics.
BioprocessingSummit.com
Next Generation Dx Summit
August 20-24, 2018 • Washington, DC
Since 2009, the diagnostics community has united at Next Generation
Dx Summit to discuss trend-setting developments, milestones,
challenges and opportunities in the industry. A decade later, the
diagnostics industry has paved the path to the precision medicine
era with tremendous advancement in rapid and non-invasive testing,
cancer detection and monitoring, and expanding applications of
clinical sequencing. As the market demands faster and more precise
diagnostics, and regulatory and reimbursement conditions continue
to evolve, diagnostic professionals need a comprehensive event
that can help them build partnerships, gain industry knowledge, and
network with and learn from their peers. Next Generation Dx Summit
provides a venue to advance the science of diagnostics and improve
the practice of medicine.
NextGenerationDx.com
The Immuno-Oncology Summit
August 27-31, 2018 • Boston, MA
Join over 600 thought leaders at industry’s leading Immuno-Oncology
event and learn about the latest research in a comprehensive 12-track
program, network and build lasting collaborations with an international
mix of delegates from industry and academia, and gain actionable
solutions to drive your organization’s next-generation immunotherapy
programs. Over the past 6 years, CHI’s Immuno-Oncology Summit
became the leading annual meeting focusing on the latest applied
research. The comprehensive 5-day, 12-track program covers
immunomodulatory antibody engineering and emerging immuno-
oncology targets, combination immunotherapy, preclinical and
translational IO, predictive biomarkers and companion diagnostics,
adoptive T cell therapy, oncolytic viruses and personalized cancer
vaccines. The Immuno-Oncology Summit brings together a unique
and international mix of large and medium pharmaceutical and biotech
companies, leading universities and clinical research institutions,
government and national labs, CROs, emerging companies and tool
providers—making the Summit a perfect meeting-place to share
experience, foster collaborations across industry and academia, and
evaluate emerging technologies. Now in its 6th year, the IO Summit
consistently delivers a cutting-edge agenda, 600+ senior delegates,
and a sold-out exhibit hall.
Immuno-OncologySummit.com
 Short Course & Training Seminar Schedule
SC = Short Course | TS = Training Seminar
Biotherapeutics Analytical Summit
March 12-16, 2018 • Baltimore, MD
SC1: Particles in Biotherapeutics: Characterization & Impact
SC2: The Multi-Attribute Method (MAM) for Improving Product and Process
Development
SC3: Critical Quality Attributes and Testing Strategy for Biotherapeutics
Development
SC4: New Analytical Approaches & Strategies for Biosimilarity
TS1: Core Principles and Best Practices for Biotech Analytical Test Methods
across the Product Lifecycle
TS2: Regulatory Requirements across the Product Development Lifecycle
BioProcessing Summit Europe
March 20-22, 2018 • Lisbon, Portugal
SC1: Optimizing Media for Culturing Cells
SC2: Continuous Processing Masterclass
SC3: At the Heart of PAT Lies the QbD Approach
SC4: The Challenge of Protein Aggregation and Sub Visible Particles in
Biopharmaceuticals
Immuno-Oncology Summit Europe
March 19-23, 2018 • London, United Kingdom
SC1: T-Cell Therapies: Current Field, Challenges and Future Directions
SC2: T-Cell Immunotherapy Manufacturing Development Challenges: Key Factors
Shaping the Field
SC3: Preclinical Models for Cancer Immunotherapy
SC4: The Tumour Microenvironment and Response to Cancer Immunotherapy
Oligonucleotide and Peptide Therapeutics
March 26-28, 2018 • Cambridge, MA
SC1: Oligonucleotide Therapeutics: From Discovery to Manufacturing
SC2: Overcoming Challenges with Peptide Delivery
SC3: CRISPR-Based Gene Editing for Targeted Therapies
Drug Discovery Chemistry
April 2-6, 2018 • San Diego, CA
SC1: Ligand-Receptor Molecular Interactions and Drug Design
SC2: Advancing Tools and Technology for Fragment-Based Design
SC3: Drug Metabolism and Its Impact on Decisions in Lead Discovery
SC4: Diversity-Oriented Platforms for Ligand Discovery
SC5: Immunology Basics for Chemists
SC6: Introduction to Allosteric Modulators and Biased Ligands of GPCRs
SC7: Introduction to Targeted Covalent Inhibitors
SC8: Introduction to the Ubiquitin Proteosome System
SC9: Impact of Convergence of Immunology and Epigenetics in Drug Discovery
SC10: Enabling Macrocyclic Compounds for Drug Discovery: Opportunities,
Challenges and Strategies
SC11: Trends in Physical Properties of Drugs
SC12: Covalent Fragments: Applications in Target-Based and Phenotypic Screens
PEGS: The Essential Protein & Antibody Engineering
Summit
April 30 - May 4, 2018 • Boston, MA
SC1: Preclinical and Clinical Assessment of Immunogenicity: Multidomain
Therapeutics and New Modalities, Including Gene Therapy and CAR T
SC2: Translational Considerations for Development of Monoclonal Antibodies
and Emerging Constructs: Part I: Focus on Construct Design
SC3: The Life Science Executive’s Fundraising Manifesto
SC4: Selection, Screening and Engineering for Affinity Reagents
SC5: In Silico Immunogenicity Predictions (Hands-on) Workshop
SC6: Practical Considerations for Biomarker Bioanalysis
SC7: Translational Considerations for Development of Monoclonal Antibodies
and Emerging Constructs: Part 2: Focus on Preclinical Development
SC8: Introduction to Biophysical Analysis for Biotherapeutics: Discovery &
Development Applications
SC9: CAR T Cell Therapy for Solid Tumors
SC10: Critical Considerations for the Design and Development of Antibody-Drug
Conjugates
SC11: Strategic/Modular Bioassay Design and Analysis
SC12: Transient Protein Production in Mammalian Cells
SC13: Sub-Visible Protein Particles in Immunogenicity: Measurement,
Characterization and Impact
TS9A: Introduction to Protein Engineering
TS10A: Introduction to Structure-Based Drug Design and Development
TS11A: Introduction to Bioprocessing
TS12A: Introduction Design of Experiments for Bioassay Development
TS9B: Next-Generation Sequencing for Antibody Discovery and Engineering
TS10B: Immunology for Drug Discovery Scientists
TS8C: Introduction to Immunogenicity
Strategic Alliance Management Congress
May 7-9, 2018 • Philadelphia, PA
SC1: The Key Skills of the Alliance Manager: Models, Tools and Frameworks for
Maximum Impact
Clinical Trial Innovation Summit
May 7-9, 2018 • Boston, MA
SC1: Needles in a Haystack: Proven Digital Media Campaigns for Clinical Trials in
Rare Diseases & Oncology
SC2: Implementing RBM and a Clinical QMS with Limited Resources
Bio-IT World
May 15-17, 2018 • Boston, MA
SC1: Data Management for Biologics: Registration and Beyond
SC2: Common Statistical Mistakes to Avoid for Data Scientists
SC3: D2K, Transforming Data to Knowledge with Cloud, IoT & Machine Learning
(AI) – Part I
SC4: Introduction to Scalable and Reproducible RNA-Seq Data Processing,
Analysis, and Result Reporting Using AWS, R, knitr, and LaTex
SC5: Data Visualization to Accelerate Biological Discovery
SC6: An Intro to Blockchain in Life Sciences
SC7: Containerizing Applications and Workflows for Large-Scale Reproducible
Science
March 2018 – August 2018 | 13
Short Course & Training Seminar Schedule
SC8: Automating Data Analysis with Excel The Bioprocessing Summit
SC9: D2K, Transforming Data to Knowledge with Cloud, IoT & Machine Learning August 13-17, 2018 • Boston, MA
(AI) – Part II SC1: Optimizing Media-Achieving Super Soup
SC10: Digital Biomarkers in Pharma R&D: Technical Challenges and Strategies SC2: QbD Strategies for Formulation Development of Protein Therapeutics
for Advancing Personalized Medicine
SC3: Operational Excellence in Bioprocessing: PAT, QbD, DoE and Continuous
SC11: Data Science Driving Better Informed Decisions Improvement
SC12: Bio-IT IOT Workshop SC4: ADC “Developability”: Critical Quality Attributes Inform Formulation
SC13: Leveraging Cloud Technologies to Enable Large-Scale Integration of SC5: Extractables & Leachables
Human Genome and Clinical Outcomes Data
SC6: Accelerated Stability Testing of Biologics
SC14: Bootstrapping Your Life Science Startup - The Good, the Bad and the Ugly
SC7: Analytical Strategies for Comparability in Bioprocess Development
SC8: Biophysical Characterization in Developing Biopharmaceuticals
Molecular Diagnostics Europe SC9: ABC: Anything But Chromatography - Precipitation, Crystallization and
May 22-24, 2018 • Lisbon, Portugal Flocculation
SC1: Technologies, Applications and Commercialization of Point-of-Care SC10: Bioprocess Development
Diagnostics TS1: Introduction to Bioprocessing
SC2: Preimplantation Genetic Diagnostics and Screening TS2: Current & Emerging Global Regulatory Expectations for Analytical Elements
SC3: Liquid Biopsy for P4 Medicine: Predictive, Preventive, Personalized and TS3: Pharmaceutical Outsourcing
Paticipatory
TS4: Introduction to Cell Culture
TS5: Introduction to Biologics Formulation and Delivery
World Preclinical Congress
June 18 - 21, 2018 • Boston, MA
Next Generation Dx Summit
SC1: Introduction to GPCR-Based Drug Discovery August 20-24, 2018 • Washington, DC
SC2: Enabling Macrocyclic Compounds for Drug Discovery SC1: Micro- and Nanofluidics in Diagnostics and Life Sciences
SC3: Drug Metabolism and Its Impact on Decisions in Lead Discovery and Drug SC2: Boosting Your Omics and Biomarker Projects through an Efficient and
Development Rigorous Study Design
SC4: Practical Phenotypic Screening SC3: Latest Advances in Molecular Pathology, Part I
SC5: Impact of Convergence of Immunotherapy and Epigenetics in Oncology SC4: Applications of Detection Theory in Diagnostics
SC6: Collecting, Storing, and Utilizing Precious Patient-Derived Tumors for Drug SC5: Automation Solutions for Molecular Diagnostics
Discovery and Development
SC6: Business Strategies for Companion Diagnostics
SC7: How to Best Utilize 3D Cells, Spheroids, PDX Models in Oncology
SC7: Latest Advances in Molecular Pathology, Part II
SC8: Applications of Artificial Intelligence & Machine Learning in Drug Discovery
SC8: The Future of Point-of-Care Diagnostics
& Development
SC9: Mass Spec Methods for the Clinical Lab
SC9: Understanding and Dealing with Drug Disposition in CNS
SC10: TBA
SC10: Humanized Mouse Models for Preclinical Assessment of Cancer
Immunotherapy SC11: TBA
SC11: DNA-Encoded Library Technologies SC12: TBA
SC12: Advanced Bioprinting Strategies for Generation of 3D Tissue Models
SC13: Evaluating and Characterizing in vitro Models of Drug Toxicity The Immuno-Oncology Summit
TS1: Introductory Immunology for Autoimmune and Cancer Drug Discovery August 27-31, 2018 • Boston, MA
TS2: Applying Pharmacology to New Drug Discovery SC1: TBA
TS3: Genome Editing with Targeted Nucleases SC2: TBA
TS4: Introduction to Small Molecule Drug Discovery and Development TS1: TBA
TS5: Practical Introduction to PKPD Modeling in Drug Discovery and
Development
TS6: Patient-Derived ASC-Organoids for Drug Development and Screening,
Patient Stratification and Regenerative Medicine

The Liquid Biopsy Summit

June 20-22, 2018 • San Diego, CA
SC1: Innovative Technologies for Imaging CTC Phenotype, Drug Response and
Metastasis

HOLD A COURSE AT YOUR FACILITY.

14 | Cambridge Healthtech Institute
For more information, please contact Edel O’Regan at 781-972-5423 or email: eoregan@healthtech.com
Increase your Sales Revenue with
Cambridge Healthtech Institute’s

LIFE SCIENCE

LEAD
GENERATION
PROGRAMS
Content marketing
designed to fill your
pipeline with
targeted leads!

Mine our database

Webinars
of 800,000 professionals
Whitepapers
Some of our database segments include:
Market Research
Antibody Engineering: 30,000 Clinical Trials: 50,000
eBooks Bioinformatics: 40,000 Diagnostics: 60,000
Bioprocessing: 40,000 Drug Discovery & Development: 35,000
Podcasts Biomarkers: 20,000 Genomics: 55,000
Cancer: 30,000 Preclinical: 35,000
Chemistry: 40,000 Proteomics: 38,000

Healthtech.com/Lead-Gen
 CHI
healthtech.com
250 First Avenue, Suite 300
Needham, Massachusetts 02494
USA Phone: 781.972.5400

About Cambridge Healthtech Institute

Your Life Science Network
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top
pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide
including PepTalk, Molecular Medicine Tri-CON, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery
Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target.

Additional divisions of CHI include

barnettinternational.com healthtechpublishing.com

insightpharmareports.com

CHI is a division of Cambridge Innovation Institute